NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/13/2023
Back to search
Official data from USPTO
IQELISA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
9
Latest update
06/13/2023
Trademark type
Word
Nice classes
1, 42
Filing date
06/20/2022
Registration date
06/13/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/13/2023
Last transaction
06/13/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/12/2018
First use in commerce
01/12/2018
Drawing code
4
Owner type
03
Owner location
Peachtree Corners, GA, US
Examiner
HILLIARD, JESSICA LYNN
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
RayBiotech Life, Inc.
Representatives
RAYBIOTECH LIFE, INC.
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Protein in raw material form for scientific and medical research; Assays and reagents for use in genetic research; Assays for research purposes; Biochemical reagents commonly known as probesfor detecting and analyzing molecules in protein or nucleotide arrays; Biochemicalsmonoclonal antibodies for in vitro scientific or research use; Diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents to monitor toxicity of drugs; Diagnostic preparations for scientific or research use; Diagnostic reagents for scientific or research use; Enzymes for scientific and research purposes; Enzymes for use in protein hydrolysis; Laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Nucleotides for scientific and research use; Protein arrays and nucleotide arrays for scientific and medical research; Reagents for research purposes; Reagents for scientific and research use; Reagents for scientific or medical research use
Class 42
Research and development of vaccines; Research and development of vaccines and medicines; Research in the field of chemistry; Research on the subject of pharmaceuticals; Research relating to environmental protection; Bacteriological research; Bacteriological research and analysis; Bacteriological research and testing; Bacteriological consultation and research; Biochemical research; Biochemical research and analysis; Biochemical research and development; Biological research; Biological research and analysis; Biomedical research services; Biotechnology research; Chemical research; Chemical research and analysis; Chemical research services; Chemicalbiochemicalbiological and bacteriological research and analysis; Dental research laboratory services; DNA screening for scientific research purposes; Drug screening for scientific research purposes; Genetic testing for scientific research purposes; Laboratory research services relating to pharmaceuticals; Medical research; Medical research in the field of infectious diseases; Medical research in the field of oncology; Medical research services; Medical research services in the field of cancer; Pharmaceutical research and development; Pharmaceutical research services; Providing information about medical research; Providing medical and scientific research information; Scientific research; Scientific research and development; Scientific research consulting; Scientific research in the field of epidemiology; Stem cell research services; Vaccine research and development; Vaccine research and development services; Zoological research and consultation
Publications
History of USPTO decisions and trademark events.
9 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/13/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/28/2023
PUBO
PUBLISHED FOR OPPOSITION
03/28/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/16/2023
DOCK
ASSIGNED TO EXAMINER
02/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/07/2022
NWAP
NEW APPLICATION ENTERED
06/23/2022
Continuous trademark protection
Get notified about every new filing that threatens IQELISA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.